Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MDA - Market Direction Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Jacob Snyder who wrote (40990)	2/22/2000 6:05:00 PM
From: Jacob Snyder	Read Replies (2) \| Respond to of 99985

Biznews, June 13, 2000: OracleBiozymeFuelCellB2BMobile.com went public today, at a price of 17, and soared to 214, before ending the day at 184. According to documents filed with the SEC, they are a "leading edge technology company, who will develop products and subcomponents in one or several emerging industries". In an exclusive interview with Biznews, the CEO has laid out the roadmap for this hot new company. According to him, the company has been intensively exploring a number of new technologies, and will decide, "in the next year or two", what industry they will be in. After that will come product development, a process which will take from 2 to 9 years. Then, of course, comes the phase of logarithmic sales increases. Asked when the company would become profitable, the CEO said, "High margins, and strong profit growth, are our number one corporate goal. But, for now, we've got to concentrate on laying the groundwork for future profits. We can't be profitable now, if we're going to invest in the future." Says Humbug and Queezy analyst Charla Ton, "We know this company best, because we are handling the IPO, for a 17% stake in it. Our objective analysis says investors should BUY BUY BUY! You can't pay too much for a company whose future prospects are unlimited. I mean, they can do anything, there are no limits to their growth. Our 12-month price target, based on EPS of 1.73 (our estimate for 2010), and a PE of 300 (the current industry average), is 519."